1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ALIVUS LIFE SCIENCES LTD.
Alivus Life Sciences Ltd. NSE: ALIVUS | BSE: 543322

Alivus Life Sciences Ltd. Live Share Price Today, Share Analysis and Chart

Mid-range Performer
about

Alivus Life Sciences is engaged in the business of development, manufacture and marketing of active pharmaceutical ingredients.

Read More
969.70 -0.60 (-0.06%)
27.37% Fall from 52W High
56,927
NSE+BSE Volume

NSE 22 Aug, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Dividend
Alivus Life Sciences Ltd. has an upcoming dividend of ₹5.00 per share due on 01 Sep 2025 See details
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
Medium Financial Strength
55.0 / 100
Valuation Score
Mid Valuation
38.5 / 100
Momentum Score
Technically Neutral
40.0 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM
Analyst Price Target
1,266
1Yr Price target upside is 31%
4 analysts

8

S

11

W

5

O

3

T

SWOT Analysis

Alivus Life Sciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
VOTE: Is Glenmark Life Sciences Ltd. worth buying?
131 Votes:
Buy 74.81%
Sell 12.21%
Hold 12.98%
BUY
SELL
HOLD